Features of clinical and laboratory manifestations of COVID-19 in outpatients one month after their recovery

Objective: to identify in patients with cardiovascular diseases (CVD), who underwent COVID-19, dynamic changes in clinical, laboratory and psychological manifestations of the disease one month after their recovery. Material and Methods. A survey was conducted among 54 CVD outpatients with confirmed COVID-19. One month after their recovery, the following was carried out: a survey about the persisting clinical manifestations; physical examination; laboratory and instrumental diagnostics; testing according to the HADS scale and the Beck scale. 34 patients agreed. Results. People aged 45–82 years were most often ill. A month after treatment, there is a decrease in the number of patients with symptoms of respiratory system damage, but symptoms of damage to other systems persist: 41.2 % — destabilization of blood pressure, 52.9 % — sleep disorders, 58.8 % — memory loss, 94.1 % — decreased exercise tolerance. When assessing the mental properties of a person, it was found that 29.4 % of respondents have subclinical and clinically severe depression. Conclusion. Within one month after treatment, there are fewer patients with cough, shortness of breath, congestion and chest pain, but they still have manifestations from the nervous and cardiovascular systems. Some individuals, after recovery, developed new symptoms: shortness of breath on exertion or at rest, swelling of the lower extremities, tachycardia, hair loss, unsteadiness or “unsteadiness” when walking